The pharmaceutical industry is at a critical juncture.
Bribery and corruption stands out as a big issue for pharmaceuticals and life sciences companies in our Global Economic Crime Survey 2014.
Innovation in pharmaceuticals has a dramatic impact both on the health and wellness of millions of people and the bottom lines of the companies in the sector.
A variety of factors can impact and frustrate consumers during their treatment experience.
The publication represents an authoritative analysis of accounting issues that the industry face.